$XXII Balance Sheet | Understand Stock

$XXII

$0.10 +$0.02 (18.67%) Live

$XXII Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investment securities
Restricted cash
Accounts receivable, net
Inventories
Insurance recoveries
GVB promissory note, net
Prepaid expenses and other current assets
Current assets of discontinued operations held for sale
Total current assets

Property, plant and equipment, net
Operating lease right-of-use assets, net
Goodwill
Intangible assets, net
Investments
Other assets
Noncurrent assets of discontinued operations held for sale
Total assets

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY
Current liabilities:
Notes payable
Notes and loans payable - current
Operating and finance lease obligations
Notes and loans payable-current
Current portion of long-term debt
Operating lease obligations
Accounts payable
Accrued expenses
Accrued expenses and other current liabilities
Accrued litigation
Accrued excise taxes and fees
Accrued severance
Deferred income
Contract liabilities
Current liabilities of discontinued operations held for sale
Accrued payroll
Other current liabilities
Total current liabilities

Long-term liabilities:
Operating and finance lease obligations
Notes and loans payable
Operating lease obligations
Severance obligations
Long-term debt
Other long-term liabilities

Total liabilities
Mezzanine equity:
Series A convertible preferred shares, $0.00001 par value; 9,650 shares issued and outstanding at September 30, 2025 and 0 at December 31, 2024, respectively
Series A Convertible Preferred Shares
Total series A convertible preferred shares, $0.00001 par value; 9,650 shares issued and outstanding at September 30, 2025 and 0 at December 31, 2024, respectively
Total mezzanine equity
Series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2026 and 9,650 at December 31, 2025, respectively
Series A Convertible Preferred Shares
Total series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2026 and 9,650 at December 31, 2025, respectively
Shareholders' equity:
Common stock, $.00001 par value, 500,000,000 shares authorized, 502,839 shares issued and outstanding at June 30, 2026 and 25,709 at December 31, 2025, respectively
Capital in excess of par value
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders' equity

Total liabilities, mezzanine equity and shareholders' equity

Comments